Anfield Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$100K Buy
1,600
+400
+33% +$27.9K 0.03% 180
2025
Q4
$79.6K Hold
1,200
0.03% 145
2025
Q3
$80.7K Hold
1,200
0.02% 147
2025
Q2
$105K Hold
1,200
0.03% 113
2025
Q1
$81.9K Hold
1,200
0.03% 117
2024
Q4
$93.3K Hold
1,200
0.03% 97
2024
Q3
$80.4K Hold
1,200
0.03% 115
2024
Q2
$136K Buy
1,200
+1,120
+1,400% +$142K 0.07% 68
2024
Q1
$11.1K Buy
+80
New +$10.1K 0.01% 148

Other funds holding DXCM

Anfield Capital Management's DXCM Position: Q1 2026 in Review

Anfield Capital Management increased its DexCom (DXCM) stake by 33% in Q1 2026, buying an estimated $27.9K and bringing the position to 1,600 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #180.

Anfield Capital Management first reported a position in DXCM in Q1 2024 and has held it in 9 quarters since. The position peaked at $136K in Q2 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Anfield Capital Management held 1,600 shares of DexCom worth $100K as of Q1 2026.
  • Anfield Capital Management bought 400 DexCom shares in Q1 2026, an estimated $27.9K.
  • DexCom made up 0.03% of Anfield Capital Management's portfolio in Q1 2026, its #180 holding.
  • Anfield Capital Management first reported a position in DexCom in Q1 2024 and has held it in 9 quarters since.
  • Anfield Capital Management's DexCom position peaked at $136K in Q2 2024.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.